PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions

AMGN vs. ABBV

Last updated Feb 24, 2024

Compare and contrast key facts about Amgen Inc. (AMGN) and AbbVie Inc. (ABBV).

Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: AMGN or ABBV.

Key characteristics


AMGNABBV
YTD Return1.19%16.02%
1Y Return25.79%21.85%
3Y Return (Ann)11.06%23.77%
5Y Return (Ann)12.45%22.92%
10Y Return (Ann)11.88%18.17%
Sharpe Ratio1.231.21
Daily Std Dev21.67%18.99%
Max Drawdown-78.03%-45.09%
Current Drawdown-10.20%0.00%

Fundamentals


AMGNABBV
Market Cap$154.98B$314.59B
EPS$12.49$2.72
PE Ratio23.1565.47
PEG Ratio2.101.66
Revenue (TTM)$28.19B$54.32B
Gross Profit (TTM)$19.92B$41.53B
EBITDA (TTM)$12.23B$26.36B

Correlation

0.50
-1.001.00

The correlation between AMGN and ABBV is 0.50, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

AMGN vs. ABBV - Performance Comparison

In the year-to-date period, AMGN achieves a 1.19% return, which is significantly lower than ABBV's 16.02% return. Over the past 10 years, AMGN has underperformed ABBV with an annualized return of 11.88%, while ABBV has yielded a comparatively higher 18.17% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-10.00%0.00%10.00%20.00%30.00%SeptemberOctoberNovemberDecember2024February
14.57%
23.79%
AMGN
ABBV

Compare stocks, funds, or ETFs


Amgen Inc.

AbbVie Inc.

AMGN vs. ABBV - Dividend Comparison

AMGN's dividend yield for the trailing twelve months is around 2.99%, less than ABBV's 3.36% yield.


TTM20232022202120202019201820172016201520142013
AMGN
Amgen Inc.
2.99%2.96%2.95%3.13%2.78%2.41%2.71%2.65%2.74%1.95%1.53%1.65%
ABBV
AbbVie Inc.
3.36%3.82%3.49%3.84%4.41%4.83%3.89%2.65%3.64%3.41%2.54%3.03%

AMGN vs. ABBV - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Amgen Inc. (AMGN) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratioSortino ratioOmega ratioCalmar ratioUlcer Index
AMGN
Amgen Inc.
1.23
ABBV
AbbVie Inc.
1.21

AMGN vs. ABBV - Sharpe Ratio Comparison

The current AMGN Sharpe Ratio is 1.23, which roughly equals the ABBV Sharpe Ratio of 1.21. The chart below compares the 12-month rolling Sharpe Ratio of AMGN and ABBV.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.50SeptemberOctoberNovemberDecember2024February
1.23
1.21
AMGN
ABBV

AMGN vs. ABBV - Drawdown Comparison

The maximum AMGN drawdown since its inception was -78.03%, which is greater than ABBV's maximum drawdown of -45.09%. The drawdown chart below compares losses from any high point along the way for AMGN and ABBV


-15.00%-10.00%-5.00%0.00%SeptemberOctoberNovemberDecember2024February
-10.20%
0
AMGN
ABBV

AMGN vs. ABBV - Volatility Comparison

Amgen Inc. (AMGN) has a higher volatility of 8.61% compared to AbbVie Inc. (ABBV) at 3.55%. This indicates that AMGN's price experiences larger fluctuations and is considered to be riskier than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


3.00%4.00%5.00%6.00%7.00%8.00%9.00%SeptemberOctoberNovemberDecember2024February
8.61%
3.55%
AMGN
ABBV